Shelf-stable mRNA delivery system targets bladder cancer cells without immune response

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
News Medical

BIOVECTRA and Revolution Biomanufacturing partner to deliver integrated mRNA Design and GMP production services

BIOVECTRA, a part of Agilent Technologies Inc., and Revolution Biomanufacturing Inc. today announced a collaboration that grants BIOVECTRA access to Revolution Biomanufacturing's proprietary platforms ...
EurekAlert!

Purdue mRNA therapy delivery system proves to be shelf-stable, storable

Research about LENN -- a patent-pending, virus-mimicking platform technology that targets bladder cancer cells with mRNA ...
News Medical

Opposing protein forces fine tune mRNA stability in human cells

A newly revealed molecular tug-of-war may have implications for better understanding how a multitude of diseases and disorders - including cancers, neurodegenerative diseases and immune disorders - ...